ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
10.49
+0.67 (6.82%)
At close: Dec 19, 2025, 4:00 PM EST
10.57
+0.08 (0.76%)
After-hours: Dec 19, 2025, 7:56 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.04 billion as of December 19, 2025. Its market cap has decreased by -26.01% in one year.
Market Cap
1.04B
Enterprise Value
918.52M
1-Year Change
-26.01%
Ranking
Category
Stock Price
$10.49
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.04B, an increase of 82.48%. That is a compound annual growth rate of 21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.04B | 1.13% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |